Security key
137404109
Candel Therapeutics, Inc. - Common Stock (CADL)
CUSIP: 137404109
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 6,345,954
- Total 13F value
- $20,561,000
- Share change
- -328,072
- SEC-reported price per share
- $3.24
- Number of holders
- 21
- Value change
- -$1,159,878
- Number of buys
- 6
- Number of sells
- 10
- Shares outstanding
- 73,256,045
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
21
Top holders
10
CADL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Candel Therapeutics, Inc. SEC filings
Candel Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 137404109
Recent filing periods:
Ownership snapshot
Top reported holders of CADL - Candel Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Laura K. Aguilar
Disclosed value leader
Northpond Ventures, LLC
Comparable rows
0/15
Latest evidence
06 May 2022
3/4/5
13F
Highest disclosed value: $9,850,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Northpond Ventures, LLC has the largest disclosed position value at $9.85M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Northpond Ventures, LLC's linked filing trail.
Disclosed position value
Top 5
Laura K. Aguilar
$2.74M
Northpond Ventures, LLC
$9.85M
FRANKLIN TEMPLETON INC
$5.73M
Sands Capital Alternatives, LLC
$4.13M
VANGUARD GROUP INC
$2.07M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Laura K. Aguilar |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$2,742,246
3,046,940 shares
|
— | 06 May 2022 |
| Northpond Ventures, LLC |
13F
Company
|
—
denominator unverified
|
$9,850,000
1,935,215 shares
|
— | 31 Mar 2022 |
| FRANKLIN TEMPLETON INC |
13F
Company
|
—
denominator unverified
|
$5,726,000
1,125,000 shares
|
— | 31 Mar 2022 |
| Sands Capital Alternatives, LLC |
13F
Company
|
—
denominator unverified
|
$4,132,000
811,737 shares
|
— | 31 Mar 2022 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$2,073,000
407,156 shares
|
— | 31 Mar 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$674,000
132,322 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
21
Shares
6,345,954
Rows available
21
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
21
Q2 2022 holders
21
Holder diff
0
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend